Pages that link to "Q34818539"

The following pages link to Respiratory microbiota: addressing clinical questions, informing clinical practice (Q34818539):

Displaying 32 items.

• Challenges in managing Pseudomonas aeruginosa in non-cystic fibrosis bronchiectasis (Q26739006) (← links)
• Current and future treatment options for cystic fibrosis lung disease: latest evidence and clinical implications (Q26747065) (← links)
• Respiratory Microbiome of New-Born Infants (Q26768244) (← links)
• The pediatric microbiome and the lung (Q26851334) (← links)
• Biomarkers, Early Diagnosis, and Clinical Predictors of Bronchopulmonary Dysplasia (Q28081434) (← links)
• The cystic fibrosis lower airways microbial metagenome (Q28596642) (← links)
• Changes in cystic fibrosis airway microbial community associated with a severe decline in lung function (Q30388877) (← links)
• Toward making inroads in reducing the disparity of lung health in Australian indigenous and new zealand māori children (Q35081103) (← links)
• Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation (Q35326173) (← links)
• The changing face of asthma and its relation with microbes (Q35594963) (← links)
• Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline (Q36063996) (← links)
• Changes in the prevalence and biofilm formation of Haemophilus influenzae and Haemophilus parainfluenzae from the respiratory microbiota of patients with sarcoidosis. (Q36113714) (← links)
• Inflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome composition (Q36932860) (← links)
• The Airway Microbiome at Birth (Q37151241) (← links)
• The human microbiome: opportunities and challenges for clinical care (Q38274423) (← links)
• How can the cystic fibrosis respiratory microbiome influence our clinical decision-making? (Q38635041) (← links)
• A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease (Q38652042) (← links)
• Precision respiratory medicine and the microbiome (Q38678093) (← links)
• Implications of the inflammatory response for the identification of biomarkers of chronic obstructive pulmonary disease. (Q38710985) (← links)
• The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease (Q38853672) (← links)
• Seasonal variation of respiratory pathogen colonization in asymptomatic health care professionals: A single-center, cross-sectional, 2-season observational study (Q38998316) (← links)
• Editorial: recent discoveries in evolutionary and genomic microbiology. (Q39691825) (← links)
• Proceedings of the COST action BM1407 inaugural conference BEAT-PCD: translational research in primary ciliary dyskinesia - bench, bedside, and population perspectives (Q40081291) (← links)
• Microbiota Promotes Chronic Pulmonary Inflammation by Enhancing IL-17A and Autoantibodies (Q40249394) (← links)
• Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. (Q46288139) (← links)
• Translational aspects of the microbiome-to be exploited (Q46560638) (← links)
• Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy (Q56523707) (← links)
• Die Bedeutung des humanen Mikrobioms für die menschliche Gesundheit (Q57003399) (← links)
• How to Process Sputum Samples and Extract Bacterial DNA for Microbiota Analysis (Q57808236) (← links)
• The pulmonary microbiome: challenges of a new paradigm (Q59355576) (← links)
• Respiratory Viral Infection-Induced Microbiome Alterations and Secondary Bacterial Pneumonia (Q59798189) (← links)
• A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease (Q62486815) (← links)